問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare (在職)

Division of Hematology & Oncology

Division of General Internal Medicine

Division of Thoracic Medicine

Tri-Service General Hospital

Division of General Surgery

Division of Hematology & Oncology

Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.

Division of Hematology & Oncology

Taipei Medical University Hospital

Division of Hematology & Oncology

Linkou Chang Gung Medical Foundation

Division of Hematology & Oncology

更新時間:2024-12-10

趙祖怡CHAO, TSU-YI
  • Principal Investigator
  • Clinical Trial Experience (year)
  • 10575@s.tmu.edu.tw

篩選

List

142Cases

2016-08-01 - 2020-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Terminated5Sites

陳訓徹
Linkou Chang Gung Medical Foundation

Division of General Surgery

2016-06-01 - 2019-12-31

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2014-09-01 - 2018-11-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Terminated10Sites

2017-09-01 - 2028-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
13Sites

Terminated11Sites

陳訓徹
Linkou Chang Gung Medical Foundation

Division of General Surgery

曾令民
Taipei Veterans General Hospital

Division of General Surgery

2014-11-06 - 2024-09-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2019-04-01 - 2027-04-24

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Recruiting10Sites

2024-02-28 - 2030-03-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2024-12-26 - 2028-10-20

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

-

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

2003-06-01 - 2006-06-01

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
15Sites

Terminated15Sites